Depending on tolerability and the need for further clinical effect, the dose may be increased to 150 mgday. Doses of 10 to 400 mgday were studied in clinical trials. Abacavir abacavir lamivudine abacavir lamivudine zidovudine acarbose acebutolol acetaminophen acetazolamide acetohexamide acetohydroxamic acid acetylsalicylic acid aspirin acrivastine acyclovir adefovir adenosine albuterol inhaled albuterol oral alfentanil alfentanil allopurinol alprazolam alteplase tissuetype plasminogen activator. Drug dosing adjustments in patients with chronic kidney disease myrna y. By continuing to browse this site you are agreeing to our use of cookies. Effexor, effexor xr venlafaxine dosing, indications. Venlafaxine therapy and cyp2d6 genotype ncbi bookshelf.
For most patients, the recommended starting dose for effexor xr is 75 mg per day, administered in a single dose. Venlafaxine effexor is a prescription drug used to treat major depression, anxiety, social phobia, and panic disorder. Side effects and discontinuations were more common at higher doses. The term renal failure denotes the inability of the kidneys to perform excretory function. The renal drug handbook the st georges hospital, adult critical. The recommended starting dose for effexor is 75 mgday, administered in two or three divided doses, taken with food. Further information can be found in clinical pharmacology textbooks such as. Supplemental doses should not be given to patients after dialysis. The use of newer antiepileptic drugs in patients with. Venlafaxine effexor side effects, dosage, interactions drugs search. Effexor xr venlafaxine hcl dosage and administration. Acute and chronic renal failure are the two kinds of kidney failure. For some patients, it may be desirable to start at 37.
Munar, pharmd, bcps, and harleen singh, pharmd oregon state university college of pharmacy, portland, oregon. Doses may be increased in daily increments of 75 mg orally at intervals of no less than 7 days. Drug dosing adjustments in patients with chronic kidney. Patient factors to consider in adjusting drug doses include the degree of renal. This book is distributed under the terms of the creative commons. This book consists of a brief introductory chapter con taining a discussion of drug ther apy in patients with renal.
220 491 597 639 1117 1506 1430 1013 661 111 1426 614 1137 80 783 1293 856 836 179 1287 294 193 621 296 966 1083 579 1044 156 1464 713 1095 488 1482 191 1098 840 479 240